{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:33:04Z","timestamp":1783038784400,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730109"],"award-info":[{"award-number":["81730109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82205052"],"award-info":[{"award-number":["82205052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Commission","doi-asserted-by":"crossref","award":["22YF1449300"],"award-info":[{"award-number":["22YF1449300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai University of TCM Budget project","award":["2021LK081"],"award-info":[{"award-number":["2021LK081"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatic stellate cells (HSCs), which contain multiple retinol-containing lipid droplets, are important profibrotic cells in liver fibrosis. Under Cyp4a12a\/b oxidation, HSC activation was accompanied by the downregulation of genes involved in retinol metabolism, inducing RAE-1 production. By eliminating activated HSCs, NK cells expressing the activating receptor NKG2D are recruited to alleviate fibrosis. FZHY was found to significantly reduce the severity of liver fibrosis by inhibiting the activation and proliferation of HSCs. The molecular processes that govern retinol metabolism, on the other hand, are largely unexplored. This study focused on the regulation of Cyp4a12a\/b by FZHY to elucidate the antifibrotic molecular mechanisms underlying the effect of FZHY on retinol metabolism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To investigate mechanisms and altered pathways of FZHY against carbon tetrachloride (CCl4)-induced liver fibrosis based on transcriptomics data. Bioinformatics analysis was used to screen its pharmacological targets. The predicted targets were confirmed by a series of in vitro and in vivo experiments, including mass spectrometry, in situ hybridization, immunofluorescence assays and real-time PCR. Then, the results were further characterized by recombinant adenovirus vectors that were constructed and transfected into the cultured primary HSCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Transcriptomics revealed that Cyp4a12a\/b is nearly completely lost in liver fibrosis, and these effects might be partially reversed by FZHY therapy recovery. In vitro and in vivo studies indicated that Cyp4a12a\/b deletion disrupted retinol metabolism and lowered Rae-1 expression. Activated HSCs successfully escape recognition and elimination by natural killer (NK) cells as a result of reduced Rae-1. Notablely, we discovered that FZHY may restore the Cyp4a12a\/b capability, allowing the recovery of the cytotoxic function of NK cells against HSCs, and thereby reducing hepatic fibrosis by suppressing HSC activation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings revealed a new role for Cyp4a in retinol metabolism in the development of hepatic fibrosis, and they highlight Cyp4a12\/Rae-1 signals as possible therapeutic targets for antifibrotic medicines.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13020-023-00754-4","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T07:31:40Z","timestamp":1683703900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe"],"prefix":"10.1186","volume":"18","author":[{"given":"Da-bing","family":"Ping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1696-6008","authenticated-orcid":false,"given":"Cheng-hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"754_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis \u2013 from bench to bedside. J Hepatol. 2003;38:38\u201353.","journal-title":"J Hepatol"},{"issue":"2","key":"754_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/hep.24384","volume":"54","author":"N Kang","year":"2011","unstructured":"Kang N, Gores GJ, Shah VH. Hepatic stellate cells: partners in crime for liver metastases? Hepatology. 2011;54(2):707\u201313.","journal-title":"Hepatology"},{"issue":"2","key":"754_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hep.30193","volume":"69","author":"E Cortes","year":"2019","unstructured":"Cortes E, et al. Retinoic acid receptor-beta is downregulated in hepatocellular carcinoma and cirrhosis and its expression inhibits myosin-driven activation and durotaxis in hepatic stellate cells. Hepatology. 2019;69(2):785\u2013802.","journal-title":"Hepatology"},{"key":"754_CR4","doi-asserted-by":"publisher","first-page":"106470","DOI":"10.1016\/j.intimp.2020.106470","volume":"84","author":"ZM Wang","year":"2020","unstructured":"Wang ZM, et al. LncRNA-H19 induces hepatic stellate cell activation via upregulating alcohol dehydrogenase III-mediated retinoic acid signals. Int Immunopharmacol. 2020;84:106470.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"754_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/labinvest.2016.53","volume":"96","author":"J Lin","year":"2016","unstructured":"Lin J, Chen A. Perilipin 5 restores the formation of lipid droplets in activated hepatic stellate cells and inhibits their activation. Lab Invest. 2016;96(7):791\u2013806.","journal-title":"Lab Invest"},{"key":"754_CR6","doi-asserted-by":"publisher","first-page":"116934","DOI":"10.1016\/j.lfs.2019.116934","volume":"238","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, et al. Oroxylin A regulates the turnover of lipid droplet via downregulating adipose triglyceride lipase (ATGL) in hepatic stellate cells. Life Sci. 2019;238:116934.","journal-title":"Life Sci"},{"issue":"4","key":"754_CR7","doi-asserted-by":"publisher","first-page":"G809","DOI":"10.1152\/ajpgi.00212.2007","volume":"293","author":"S Radaeva","year":"2007","unstructured":"Radaeva S, et al. Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol. 2007;293(4):G809\u201316.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"754_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.exer.2011.06.019","volume":"102","author":"DS Mackay","year":"2012","unstructured":"Mackay DS, Halford S. Focus on molecules: cytochrome P450 family 4, subfamily V, polypeptide 2 (CYP4V2). Exp Eye Res. 2012;102:111\u20132.","journal-title":"Exp Eye Res"},{"issue":"7","key":"754_CR9","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1194\/jlr.M002840","volume":"51","author":"L Qian","year":"2010","unstructured":"Qian L, Zolfaghari R, Ross AC. Liver-specific cytochrome P450 CYP2C22 is a direct target of retinoic acid and a retinoic acid-metabolizing enzyme in rat liver. J Lipid Res. 2010;51(7):1781\u201392.","journal-title":"J Lipid Res"},{"issue":"8","key":"754_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/17425250903032681","volume":"5","author":"JE Thatcher","year":"2009","unstructured":"Thatcher JE, Isoherranen N. The role of CYP26 enzymes in retinoic acid clearance. Expert Opin Drug Metab Toxicol. 2009;5(8):875\u201386.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"754_CR11","doi-asserted-by":"publisher","first-page":"4494099","DOI":"10.1155\/2022\/4494099","volume":"2022","author":"T Hassanein","year":"2022","unstructured":"Hassanein T, et al. Efficacy and safety of a botanical formula Fuzheng Huayu for hepatic fibrosis in patients with CHC: results of a phase 2 clinical trial. Evid Based Complement Alternat Med. 2022;2022:4494099.","journal-title":"Evid Based Complement Alternat Med"},{"key":"754_CR12","doi-asserted-by":"publisher","first-page":"115599","DOI":"10.1016\/j.jep.2022.115599","volume":"298","author":"ZM Zhao","year":"2022","unstructured":"Zhao ZM, et al. Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: a single arm clinical objective performance criteria trial. J Ethnopharmacol. 2022;298:115599.","journal-title":"J Ethnopharmacol"},{"key":"754_CR13","doi-asserted-by":"publisher","first-page":"3468791","DOI":"10.1155\/2020\/3468791","volume":"2020","author":"M Wu","year":"2020","unstructured":"Wu M, et al. Fuzheng Huayu capsule attenuates hepatic fibrosis by inhibiting activation of hepatic stellate cells. Evid Based Complement Alternat Med. 2020;2020:3468791.","journal-title":"Evid Based Complement Alternat Med"},{"key":"754_CR14","doi-asserted-by":"publisher","first-page":"805432","DOI":"10.3389\/fphar.2022.805432","volume":"13","author":"F Jing","year":"2022","unstructured":"Jing F, et al. An Herbal product alleviates Bleomycin-Induced Pulmonary Fibrosis in mice via regulating NF-kappaB\/TNF-alpha signaling in macrophages. Front Pharmacol. 2022;13:805432.","journal-title":"Front Pharmacol"},{"issue":"2","key":"754_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva S, et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology. 2006;130(2):435\u201352.","journal-title":"Gastroenterology"},{"issue":"1","key":"754_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","volume":"112","author":"IS Jamall","year":"1981","unstructured":"Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem. 1981;112(1):70\u20135.","journal-title":"Anal Biochem"},{"issue":"1","key":"754_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/13880209.2020.1748661","volume":"58","author":"Z Xu","year":"2020","unstructured":"Xu Z, et al. A high-throughput assay for screening natural products that boost NK cell-mediated killing of cancer cells. Pharm Biol. 2020;58(1):357\u201366.","journal-title":"Pharm Biol"},{"issue":"1","key":"754_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","volume":"14","author":"DR Nelson","year":"2004","unstructured":"Nelson DR, et al. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 2004;14(1):1\u201318.","journal-title":"Pharmacogenetics"},{"issue":"2","key":"754_CR19","doi-asserted-by":"publisher","first-page":"G417","DOI":"10.1152\/ajpgi.00294.2003","volume":"287","author":"JA Dranoff","year":"2004","unstructured":"Dranoff JA, et al. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2004;287(2):G417\u201324.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"19","key":"754_CR20","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1182\/blood-2012-08-445130","volume":"121","author":"X Chen","year":"2013","unstructured":"Chen X, et al. A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease. Blood. 2013;121(19):3970\u201380.","journal-title":"Blood"},{"issue":"1","key":"754_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cei.12186","volume":"175","author":"GD Sckisel","year":"2014","unstructured":"Sckisel GD, et al. Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function. Clin Exp Immunol. 2014;175(1):79\u201391.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"754_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology. 2022;75(2):473\u201388.","journal-title":"Hepatology"},{"key":"754_CR23","doi-asserted-by":"publisher","first-page":"e9838","DOI":"10.7717\/peerj.9838","volume":"8","author":"JM Coelho","year":"2020","unstructured":"Coelho JM, et al. Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study. PeerJ. 2020;8:e9838.","journal-title":"PeerJ"},{"issue":"1","key":"754_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbadis.2006.08.009","volume":"1772","author":"L Wang","year":"2007","unstructured":"Wang L, et al. Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochim Biophys Acta. 2007;1772(1):66\u201371.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"754_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/jcp.25921","volume":"233","author":"H Shimizu","year":"2018","unstructured":"Shimizu H, et al. All-trans retinoic acid ameliorates hepatic stellate cell activation via suppression of thioredoxin interacting protein expression. J Cell Physiol. 2018;233(1):607\u201316.","journal-title":"J Cell Physiol"},{"issue":"1","key":"754_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells9010024","volume":"9","author":"O Khomich","year":"2019","unstructured":"Khomich O, Ivanov AV, Bartosch B. Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells. 2019;9(1):24.","journal-title":"Cells"},{"issue":"6","key":"754_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1074-7613(00)80222-8","volume":"12","author":"A Cerwenka","year":"2000","unstructured":"Cerwenka A, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 2000;12(6):721\u20137.","journal-title":"Immunity"},{"key":"754_CR28","doi-asserted-by":"publisher","first-page":"108846","DOI":"10.1016\/j.biopha.2019.108846","volume":"114","author":"J Chen","year":"2019","unstructured":"Chen J, et al. The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases. Biomed Pharmacother. 2019;114:108846.","journal-title":"Biomed Pharmacother"},{"key":"754_CR29","doi-asserted-by":"publisher","first-page":"8591892","DOI":"10.1155\/2020\/8591892","volume":"2020","author":"M Zhang","year":"2020","unstructured":"Zhang M, et al. Fuzheng Huayu recipe prevented and treated CCl4-induced mice liver fibrosis through regulating polarization and chemotaxis of intrahepatic macrophages via CCL2 and CX3CL1. Evid Based Complement Alternat Med. 2020;2020:8591892.","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-023-00754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-023-00754-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-023-00754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:00:43Z","timestamp":1683705643000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-023-00754-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1186\/s13020-023-00754-4","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"5 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures complied with the Guidelines for Experimentation of Shuguang Hospital, affiliated with Shanghai University of Traditional Chinese Medicine. The protocols were reviewed and approved by the Ethics Committee of the institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript and its submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}